Slow fetal growth, unspecified. Disorders related to short gestation and low birth weight, not elsewhere classified
Conditions
Interventions
Intervention 1: first group utrogesterone tablets received 100 mg twice daily per orally with routine treatment (high protein and resting) until Until thirty-eight weeks of pregnancy. Intervention 2:
Treatment - Drugs
first group utrogesterone tablets received 100 mg twice daily per orally with routine treatment (high protein and resting) until Until thirty-eight weeks of pregnancy
in control group receive routine treatment Until thirty-eight weeks of pregnancy
Sponsors
Vice chancellor for research of Shahrekord University of Medical Science
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: pregnant women with an idiopathic IUGR embryo; Singleton pregnancy; Having BMI 25-19; Women at the gestational age of 34-28 weeks Exclusion criteria: Women with embryos with congenital or chromosomal anomalies and embryonic infections that cause IUGR simptrics; uterine anomalies, as well as fetal infections such as TORCH, which causes IUGR to be symmetric
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood flow to the fetus. Timepoint: once a week. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBelgheyse Mohammadi
Shahrekord University of Medical Sciences
Outcome results
None listed